CTL Statement Regarding Business Operations during the COVID-19 Pandemic

Dear Valued Clients and Suppliers:

As concerns about the spread of COVID-19 increase, Cellular Technology Limited’s and CTL Analyzers, LLC’s (collectively, “CTL”) top priorities are the health and safety of our employees, customers, suppliers and others. During this pandemic, CTL has taken a number of extra precautionary safety and health measures to minimize the risk of exposure to our employees and others.

We assure you that CTL will continue to take measures to provide uninterrupted industry leading support and services to our clients and others. Although we have temporarily suspended business travel, we are fully operational, while some of our personnel will be conducting business remotely from home.

As an immune monitoring biotechnology company that provides operations, research and development, manufacturing, and supply chain services for a number of different sectors, CTL is a company that is allowed to operate and stay open under the terms of the Director’s Stay at Home Order issued by the Director of the Ohio Department of Health on March 22, 2020. CTL is part of a critical infrastructure industry, as defined by the Department of Homeland Security, in that the pharmaceutical and biotech industries are considered essential.

If you have any legal questions regarding CTL’s continued operations, please contact our attorney, Keith E. Blaha, General Counsel of CTL. He can be reached at +1-216-325-9179 or via email at keith.blaha@immunospot.com.

If you have questions regarding specific products or services, please contact our respective representatives via our regular channels.

CTL Executive Management